Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
7.90
+0.14 (1.80%)
Aug 1, 2025, 2:45 PM CST
Intra-Cellular Therapies Market Cap
Guangdong VTR Bio-Tech has a market cap or net worth of 3.79 billion as of August 1, 2025. Its market cap has increased by 27.68% in one year.
Market Cap
3.79B
Enterprise Value
3.14B
Revenue
829.76M
Ranking
n/a
PE Ratio
237.52
Stock Price
$7.90
Market Cap Chart
Since January 28, 2014, Guangdong VTR Bio-Tech's market cap has increased from 1.84B to 3.79B, an increase of 106.24%. That is a compound annual growth rate of 6.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 3.79B | 12.54% |
Dec 31, 2024 | 3.37B | -4.55% |
Dec 29, 2023 | 3.53B | -4.20% |
Dec 30, 2022 | 3.69B | -36.63% |
Dec 31, 2021 | 5.82B | 9.40% |
Dec 31, 2020 | 5.32B | 24.97% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 419.66B |
Shenzhen Mindray Bio-Medical Electronics | 279.61B |
WuXi AppTec | 274.21B |
Sichuan Biokin Pharmaceutical | 123.27B |
Zhangzhou Pientzehuang Pharmaceutical., | 120.05B |
Aier Eye Hospital Group | 119.45B |
Shanghai United Imaging Healthcare | 109.31B |
Yunnan Baiyao Group Co.,Ltd | 100.06B |